CVS Health reached a deal with Glenview Capital for four board seats after the ousting of former chief Karen Lynch. Glenview CEO Larry Robbins and three other directors will join the board to enhance value for stakeholders. CVS faces challenges and cost-cutting measures amid activist settlements in the industry.